A Concise Enantioselective Synthesis of (+)-L-733,060 and (+)-T-2328 via Sequential Proline Catalysis

Komal G. Lalwani; Arumugam Sudalai

doi:10.1055/s-0035-1561346

Synlett, Inhaltsverzeichnis

Synlett 2016; 27(09): 1339-1343
DOI: 10.1055/s-0035-1561346

letter

A Concise Enantioselective Synthesis of (+)-L-733,060 and (+)-T-2328 via Sequential Proline Catalysis

Komal G. Lalwani

Chemical Engineering and Process Development Division, National Chemical Laboratory, Pashan Road, Pune 411008, India eMail: a.sudalai@ncl.res.in

,

Arumugam Sudalai*

Chemical Engineering and Process Development Division, National Chemical Laboratory, Pashan Road, Pune 411008, India eMail: a.sudalai@ncl.res.in

› Institutsangaben

Abstract

Alle Artikel dieser Rubrik

Abstract

A new, sequential proline-catalyzed approach to the synthesis of (+)-L-733,060 and (+)-T-2328 in high optical purity (93% ee) is described starting from phenyl N-Boc imine. The strategy involves proline-catalyzed Mannich reaction of an arylimine with acetaldehyde followed by α-aminoxylation/Wittig olefination in a sequential fashion as the key steps.

Key words

imine - Mannich reaction - aminoxylation - olefination - sequential

Volltext

Referenzen

References

1a Remuson R, Gelas-Mialhe Y. Mini-Rev. Org. Chem. 2008; 5: 193
1b Reynolds T. Phytochemistry 2005; 66: 1399
1c O’Hagan D. Nat. Prod. Rep. 2000; 17: 435
1d Aguinaldo AM, Read RW. Phytochemistry 1990; 29: 2309
1e Ahmad A, Khan KA, Ahmad VU, Qazi S. Planta Med. 1986; 4: 285
1f Bols M. Acc. Chem. Res. 1998; 31: 1
1g Bailey PD, Millwood PA, Smith PD. Chem. Commun. 1998; 633
1h Mitchinson A, Nadin A. J. Chem. Soc., Perkin Trans. 1 1999; 2553

2a Watson PS, Jiang B, Scott B. Org. Lett. 2000; 2: 3679 ; and references cited therein
2b A substructure search of cis-2,3-disubstituted piperidines using the SciFinder data search engine revealed that there are a great number of piperidine derivatives mentioned in patents because of their bioactivity in clinical and preclinical studies.

3a Baker R, Harrison T, Hollingworth GJ, Swain CJ, Williams BJ. EP 528495A1, 1993
3b Harrison T, Williams BJ, Swain CJ, Ball RG. Bioorg. Med. Chem. Lett. 1994; 4: 2545

4a Takahashi M, Miyake T, Yamakita H, Saito A, Asai H. US 0097548A1, 2004
4b Watanabe Y, Asai H, Ishii T, Kiuchi S, Okamoto M, Taniguchi H, Nagasaki M, Saito A. J. Pharmacol. Sci. 2008; 106: 121
4c Watanabe Y, Okamoto M, Ishii T, Takatsuka S, Taniguchi H, Nagasaki M, Saito A. J. Pharmacol. Sci. 2008; 107: 151

5 Desai MC, Lefkowitz SL, Thadeio PF, Longo KP, Snider RM. J. Med. Chem. 1992; 35: 4911

6a Koepfli JB, Mead JF, Brockman JA. J. Am. Chem Soc. 1947; 69: 1837
6b Koepfli JB, Mead JF, Brockman JA. J. Am. Chem Soc. 1949; 71: 1048

7 Cochi A, Pardo DG, Cossy J. Heterocycles 2012; 86: 89

8a Oshitari T, Mandai T. Synlett 2006; 3395
8b Devalankar DA, Chouthaiwale PV, Sudalai A. Synlett 2014; 25: 102

9a Huang P.-Q, Liu L.-X, Wei B.-G, Ruan Y.-P. Org. Lett. 2003; 5: 1927
9b Bhaskar G, Rao BV. Tetrahedron Lett. 2003; 44: 915
9c Yoon Y.-J, Joo J.-E, Lee K.-Y, Kim Y.-H, Oh C.-Y, Ham W.-H. Tetrahedron Lett. 2005; 46: 739
9d Cochi A, Burger B, Navarro C, Gomez Pardo D, Cossy J, Zhao Y, Cohen T. Synlett 2009; 2157
9e Prévot S, Phansavath P, Haddad M. Tetrahedron: Asymmetry 2010; 21: 16

10a Liu R.-H, Fang K, Wang B, Xu M.-H, Lin G.-Q. J. Org. Chem. 2008; 73: 3307
10b Davis FA, Ramachandar T. Tetrahedron Lett. 2008; 49: 870
10c Hélal B, Ferreira F, Botuha C, Chemla F, Pérez-Luna A. Synlett 2009; 3115
10d Garrido NM, Garcia M, Sanchez MR, Diez D, Urones JG. Synlett 2010; 387
10e Lemire A, Grenon M, Pourasharf M, Charette AB. Org. Lett. 2004; 6: 3517

11 Kandula SR. V, Kumar P. Tetrahedron: Asymmetry 2005; 16: 3579

12a Cherian SK, Kumar P. Tetrahedron: Asymmetry 2007; 18: 982
12b Emmanuvel L, Sudalai A. Tetrahedron Lett. 2008; 49: 5736

13 Bilke JL, Moore SP, O’Brien P, Gilday J. Org. Lett. 2009; 11: 1935
14 Takahashi K, Nakano H, Fujita R. Tetrahedron Lett. 2005; 46: 8927
15 Kumaraswamy G, Pitchaiah A. Tetrahedron 2011; 67: 2536
16 Pansare SV, Paul EK. Org. Biomol. Chem. 2012; 10: 2119

17a Chowdari NS, Ramachary DB, Barbas CF. III. Org. Lett. 2003; 5: 1685
17b Zhong G, Yu Y. Org. Lett. 2004; 6: 1637
17c Zhong G. Chem Commun. 2004; 606
17d Liao WW, Ibrahem I, Cordova A. Chem. Commun. 2006; 674
17e Kotkar SP, Chavan VB, Sudalai A. Org. Lett. 2007; 9: 1001
17f Coeffard V, Desmarchelier A, Morel B, Moreau X, Greck C. Org. Lett. 2011; 13: 5778
17g Kumar BS, Venkataramasubramanian V, Sudalai A. Org. Lett. 2012; 14: 2468
17h Lalwani KG, Aher RD, Sudalai A. RSC Adv. 2015; 5: 65554
17i Venkataramasubramanian V, Kiran IN. C, Sudalai A. Synlett 2015; 26: 355
17j Ahuja BB, Sudalai A. RSC Adv. 2015; 5: 21803
17k Rawat V, Kumar BS, Sudalai A. Org. Biomol. Chem. 2013; 11: 3608
17l Aher RD, Kumar BS, Sudalai A. J. Org. Chem. 2015; 80: 2024

18a Kotkar SP, Chavan VB, Sudalai A. Org. Lett. 2007; 9: 1001
18b Kotkar SP, Sudalai A. Tetrahedron Lett. 2006; 47: 6813
18c Rawat V, Chouthaiwale PV, Chavan VB, Suryavanshi G, Sudalai A. Tetrahedron Lett. 2010; 51: 6565
18d Ahuja BB, Sudalai A. Tetrahedron: Asymmetry 2015; 26: 548
18e Ahuja BB, Sudalai A. Tetrahedron: Asymmetry 2015; 26: 24

19 Yang JW, Chandler C, Stadler M, Kampen D, List B. Nature 2008; 452: 453
20 Zhong G. Angew. Chem. Int. Ed. 2003; 42: 4247
21 α-Aminoxylation/Wittig Olefination To a stirred precooled (–10 °C) MeCN (15 mL) solution of β-aminoaldehyde 6 (1 g, 4.01 mmol) and nitrosobenzene (360 mg, 3.34 mmol) was added l-proline (77 mg, 20 mol%). The mixture was allowed to stir at the same temperature for 20 h followed by the addition of Ph₃P=CHCO₂ t-Bu (1.91 g, 5.01 mmol) to the reaction mixture, which was stirred for a further 6 h at 0–25 °C. After addition of phosphate buffer, the resulting mixture was extracted with EtOAc (3 × 30 mL) and the combined organic phases were dried over anhyd Na₂SO₄, filtered and concentrated to give the crude aminoxy unsaturated ester that was directly taken to the next step without purification. To a MeOH (20 mL) solution of the above crude aminoxy unsaturated ester was added Cu(OAc)₂·2H₂O (140 mg, 0.67 mmol) at 25 °C and the reaction mixture was allowed to stir for 10 h at the same temperature. After addition of phosphate buffer, the resulting mixture was extracted with CHCl₃ (3 × 30 mL) and the combined organic phases were dried over anhyd. Na₂SO₄, filtered and concentrated. The crude residue was purified by column chromatography over silica gel using PE–EtOAc (7.5:2.5) to give syn-aminohydroxycinnamic ester 5. Yield: 1.02 g (70%); colorless liquid; [α]_D ²⁵ +11.5 (c 1.0, CHCl₃); ee = 93% [chiral HPLC analysis (Chiracel AD-H 250 × 4.6 mm), n-hexane/i-PrOH, (80:20) 0.5 mL/min, 254 nm), t _R = 27.200 min (minor), t _R = 30.607 min (major). IR (CHCl₃): 1322, 1463, 1522, 1621, 1719, 3342 cm^–1. ¹H NMR (200 MHz, CDCl₃): δ = 1.41 (s, 9 H), 1.47 (s, 9 H), 2.51 (br s, 1 H), 4.51–4.58 (m, 1 H), 4.72–4.80 (m, 1 H), 5.30 (d, J = 8.1 Hz, 1 H), 6.06 (dd, J = 1.9, 15.7 Hz, 1 H), 6.80 (dd, J = 4.9, 15.7 Hz, 1 H), 7.30–7.37 (m, 5 H). ¹³C NMR (50 MHz, CDCl₃): δ = 28.1, 28.3, 58.8, 74.3, 80.1, 80.5, 124.1, 126.8, 127.9, 128.8, 145.1, 156.1, 165.5. HRMS (ESI): m/z [M + Na]⁺ calcd for C₂₀H₂₉NNaO₅: 386.1938; found: 386.1919.
22 Sajiki H. Tetrahedron Lett. 1995; 36: 3465
23 (+)-L-733,060 (1) Yield: 98 mg (95%); colorless liquid; [α]_D ²⁵ +31.99 (c 1.32, CHCl₃) {lit.^9b [α]_D ²⁵ +34.29 (c 1.32, CHCl₃)}. IR (CHCl₃): 660, 877, 1123, 1170, 1370, 1577, 2950 cm^–1. ¹H NMR (400 MHz, CDCl₃): δ = 1.54 (d, J = 13.9 Hz, 1 H), 1.66–1.75 (m, 1 H), 1.84–1.93 (m, 1 H), 2.85 (td, J = 2.7, 12.2 Hz, 1 H), 3.29 (d, J = 12.0 Hz, 1 H), 3.68 (s, 1 H), 3.86 (s, 1 H), 4.14 (d, J = 12.7 Hz, 1 H), 4.53 (d, J = 12.7 Hz, 1 H), 7.28–7.37 (m, 5 H), 7.44 (s, 2 H), 7.69 (s, 1 H). ¹³C NMR (100 MHz, CDCl₃): δ = 20.4, 28.4, 47.0, 64.2, 70.0, 121.2 (m), 124.6 (q, J = 270 Hz), 126.8, 127.2, 127.5, 128.2, 131.2 (q, J = 33.1 Hz), 141.1, 141.6. HRMS (ESI): m/z [M + H]⁺ calcd for C₂₀H₂₀ONF₆: 404.1444; found: 404.1429.
24 Ayedi MA, Le Bigot Y, Ammar H, Abid S, El Gharbi R, Delmas M. Synth. Commun. 2013; 43: 2127
25 4-Cyano-2-fluorophenyl trifluoromethanesulfonate (14) was prepared from 4-bromo-2-fluorophenol. For experimental details, refer to the supporting information.

26a Kulagowski JJ, Curtis NR, Swain CJ, Williams BJ. Org. Lett. 2001; 3: 667
26b Atobe M, Yamazaki N, Kibayashi C. J. Org. Chem. 2004; 69: 5595

27 (+)-T-2328 Dihydrochloride Salt (3) Yield: 38 mg (quant.); colorless solid; mp 279–281 °C (lit.^4a 280–281 °C); [α]_D ²⁵ +70.1 (c 0.6, H₂O). IR (CHCl₃): 680, 889, 1128, 1250, 1370, 1556, 2923, 3350 cm^–1. ¹H NMR (400 MHz, D₂O): δ = 2.07 (s, 2 H), 2.25 (d, J = 7.8 Hz, 1 H), 2.46 (d, J = 14.9 Hz, 1 H), 3.29 (quin, J = 7.3 Hz, 1 H), 3.60 (s, 3 H), 3.66–3.72 (m, 1 H), 4.02 (dd, J = 3.4, 16.1 Hz, 2 H), 4.29 (d, J = 13.2 Hz, 1 H), 4.92 (d, J = 2.9 Hz, 1 H), 7.25 (d, J = 6.6 Hz, 2 H), 7.32 (s, 1 H), 7.44 (d, J = 7.1 Hz, 3 H), 7.49–7.58 (m, 4 H). ¹³C NMR (100 MHz, D₂O): δ = 16.8, 22.7, 43.3, 47.5, 55.3, 55.6, 58.0, 110.9, 111.6, 117.2, 118.4, 119.9 (d, J = 27.0 Hz), 126.2, 126.4, 128.9 (d, J = 3.1 Hz), 129.8, 130.0, 130.4, 131.2, 132.0, 132.6 (d, J = 3.1 Hz), 132.7, 157.4, 157.7 (d, J = 248 Hz). HRMS (ESI): m/z [M + H]⁺ calcd for C₂₆H₂₇ON₃F: 416.2133; found: 416.2114.

Zusatzmaterial

Supporting Information